Santana Jessica Gois, Shewarega Annabella, Nam David, Duncan James, Madoff David Craig, Hyder Fahmeed, Coman Daniel, Chapiro Julius
Department of Biomedical Engineering, Yale University, New Haven, CT, United States.
Department of Radiology and Biomedical Imaging, Yale School of Medicine, 333 Cedar Street, New Haven, CT 06510, United States.
JHEP Rep. 2024 Dec 4;7(3):101294. doi: 10.1016/j.jhepr.2024.101294. eCollection 2025 Mar.
BACKGROUND & AIMS: Increasing enthusiasm around integrating locoregional therapy with systemic immunotherapy in primary liver cancer underscores the need for non-invasive imaging biomarkers. In this study, we aimed to establish advanced molecular MRI tools for monitoring T-cell responses to cryoablation in murine models, distinguishing between immunologically "hot" and "cold" hepatocellular carcinoma (HCC).
Immunocompetent 7-10-week-old C57BL/6J and BALB/cJ mice (n = 18 each) received carbon tetrachloride for 12 weeks to induce cirrhosis. Intrinsically immunogenic Hepa1-6 ("hot") and non-immunogenic TiB75 ("cold") cells were orthotopically implanted into C57BL/6 or BALB/c mice, respectively, to generate focal HCC lesions. After one week, animals were randomly assigned to (A) partial cryoablation (pCryo) (1.2 mm cryoprobe, -40 °C) or (B) no treatment (n = 8 per group and tumor type). Gadolinium 160 (Gd)-labeled CD8 antibody was administered intravenously either 1 week after tumor induction (control) or 1-week post (pCryo) (treatment). T1-weighted MRI scans were performed using a 9.4 T MRI scanner. Radiological-pathological correlation included imaging mass cytometry and immunohistochemistry.
pCryo-treated Hepa1-6 tumors displayed peritumoral ring enhancement on T1-weighted MRI with Gd-CD8, correlating with imaging mass cytometry signal patterns. Untreated Hepa1-6 tumors lacked such enhancement. Radiological-pathological correlation confirmed significantly increased tumor-infiltrating CD8 T lymphocytes in pCryo Hepa1-6 tumors compared with untreated tumors ( <0.001), and a stronger local response compared with systemic lymph nodes ( = 0.0415). Increased T-lymphocyte infiltration was not observed in TiB75 tumors, as indicated by MRI and histopathology.
pCryo induced increased T-cell infiltration in Hepa1-6 tumors compared to TiB75 tumors. T1-weighted MRI, following Gd-CD8 antibody administration, reproducibly detected the ablation-induced changes. These findings encourage further investigation of MRI-based molecular imaging biomarkers to assess immune responses to local tumor therapies.
This study successfully established reliable MR-based molecular imaging tools to visualize CD8 anti-tumor specific T-cell infiltration following partial cryoablation (pCryo) in murine tumor models. The study's significance lies in advancing our understanding of immune responses within induced cirrhosis and distinguishing between "hot" and "cold" tumor phenotypes. The findings not only build upon previous proof-of-principle data but also extend this technology to include different immune cell types in hepatocellular carcinoma. The study reveals that pCryo may exert specific effects on the tumor microenvironment, augmenting the anti-tumor immune response in immunogenic tumors while displaying a weaker local effect in non-immunogenic tumors.
在原发性肝癌中,将局部区域治疗与全身免疫治疗相结合的热情日益高涨,这凸显了对非侵入性成像生物标志物的需求。在本研究中,我们旨在建立先进的分子磁共振成像(MRI)工具,用于监测小鼠模型中T细胞对冷冻消融的反应,区分免疫性“热”和“冷”肝细胞癌(HCC)。
7至10周龄的免疫活性C57BL/6J和BALB/cJ小鼠(每组n = 18只)接受四氯化碳处理12周以诱导肝硬化。将具有内在免疫原性的Hepa1-6(“热”)和非免疫原性的TiB75(“冷”)细胞分别原位植入C57BL/6或BALB/c小鼠体内,以产生局灶性HCC病变。一周后,将动物随机分为(A)部分冷冻消融(pCryo)组(1.2毫米冷冻探头,-40°C)或(B)未治疗组(每组每种肿瘤类型n = 8只)。在肿瘤诱导后1周(对照组)或pCryo后1周(治疗组)静脉注射钆160(Gd)标记的CD8抗体。使用9.4T MRI扫描仪进行T1加权MRI扫描。放射学-病理学相关性包括成像质谱流式细胞术和免疫组织化学。
pCryo治疗的Hepa1-6肿瘤在T1加权MRI上显示钆- CD8的瘤周环形强化,与成像质谱流式细胞术信号模式相关。未治疗的Hepa1-6肿瘤缺乏这种强化。放射学-病理学相关性证实,与未治疗的肿瘤相比,pCryo处理的Hepa1-6肿瘤中肿瘤浸润性CD8 T淋巴细胞显著增加(<0.001),与全身淋巴结相比局部反应更强(P = 0.0415)。MRI和组织病理学显示,TiB75肿瘤中未观察到T淋巴细胞浸润增加。
与TiB75肿瘤相比,pCryo诱导Hepa1-6肿瘤中T细胞浸润增加。注射Gd-CD8抗体后,T1加权MRI可重复性地检测到消融诱导的变化。这些发现鼓励进一步研究基于MRI的分子成像生物标志物,以评估对局部肿瘤治疗的免疫反应。
本研究成功建立了可靠的基于磁共振的分子成像工具,以可视化小鼠肿瘤模型中部分冷冻消融(pCryo)后CD8抗肿瘤特异性T细胞浸润。该研究的意义在于加深我们对诱导性肝硬化内免疫反应的理解,并区分“热”和“冷”肿瘤表型。这些发现不仅基于先前的原理验证数据,还将该技术扩展到包括肝细胞癌中的不同免疫细胞类型。该研究表明,pCryo可能对肿瘤微环境产生特定影响,增强免疫原性肿瘤中的抗肿瘤免疫反应,而在非免疫原性肿瘤中显示较弱的局部效应。